Skip to main content
Clinical Trials/ACTRN12612000787886
ACTRN12612000787886
Completed
Phase 2

In infants with a family history of allergic disease, vitamin D supplementation from birth to 6 months of age will be compared to no vitamin D supplementation on the outcomes of infant vitamin D status and immune function.

niversity of Western Australia0 sites195 target enrollmentJuly 25, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Allergic Disease
Sponsor
niversity of Western Australia
Enrollment
195
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2012
End Date
January 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Western Australia

Eligibility Criteria

Inclusion Criteria

  • Term singleton infants who have a first degree relative with a history of allergic disease.

Exclusion Criteria

  • Maternal vitamin D serum concentration \<50 nmol/L or \>100 nmol/L between 36\-40 weeks gestation.
  • Maternal smoking during pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials